Japanese Encephalitis Vaccines (JEV) Market Analysis Asia, Rest of World (ROW), Europe, North America - South Korea, Australia, China, India, Japan - Size and Forecast 2024-2028

Published: Feb 2024 Pages: 150 SKU: IRTNTR70257

Japanese Encephalitis Vaccines (JEV) Market Forecast 2024-2028

The Japanese Encephalitis Vaccines (JEV) Market size is forecast to increase by USD 75.69 million, at a CAGR of 6.29% between 2023 and 2028. 

What will be the Size of the Japanese Encephalitis Vaccines Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Type, Distribution Channel, and Geography Analysis

Type Analysis

Inactivated vaccines

The inactivated vaccines segment is estimated to witness significant growth during the forecast period. Inactivated vaccine segments are developed by inactivating the live microorganisms that cause disease through physical or chemical processes. In addition, the pathogens are grown under controlled conditions and are killed to ensure that they do not cause any infection when administered. Furthermore, inactivated vaccines are developed by inactivating or killing a pathogen using heat or chemicals.

Get a glance at the market contribution of various segments Download PDF Sample

The inactivated vaccines segment was the largest segment and was valued at USD 132.44 million in 2018. Moreover, formaldehyde or formalin is the most commonly used chemical to inactivate a pathogen. In addition,  when exposed to these chemicals, the pathogen loses its ability to replicate, and hence, it does not cause any harm to the body. Furthermore, the pathogen is kept intact or is left with some of its integrity to ensure that the immune system recognizes it and starts an immune response. In addition, the inactivated vaccines hold the highest share of the global market in 2023, with approximately seven vaccines approved under this segment. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Distribution Channel Analysis

Hospital pharmacy

The hospital pharmacies segment works closely with suppliers and pharmaceutical companies to procure the necessary Japanese encephalitis vaccines. In addition, these vaccines are then stored in the pharmacy inventory. Inventory management systems help monitor stock levels and ensure that an adequate supply of Japanese encephalitis vaccines is available. Moreover, accurate documentation is crucial in healthcare. In addition, hospital pharmacies maintain records of the medications dispensed to each patient. Furthermore, this helps in tracking the patient treatment progress and ensures accountability. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Retail pharmacy

Retail pharmacies, comprising chain pharmacies, independent pharmacies, and online pharmacies, play a significant role in the distribution process of Japanese encephalitis vaccines. In addition, retail pharmacists provide patient education on proper medication usage, potential side effects, and any relevant precautions. Moreover, this education helps patients understand how to effectively manage their Japanese encephalitis condition. In addition, retail pharmacies maintain records of dispensed medications and patient information. Furthermore, this documentation is essential for record-keeping, patient history, and potential future interactions. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

Asia is estimated to contribute 72% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market in Asia is expected to witness significant growth, due to the increased risk of the indication in the region. In addition, Japanese encephalitis is endemic mostly in Asian countries, thus increasing the risk of the indication in over three billion people in the region. Moreover, as there is no cure for the disease, various vendors, such as Sanofi, Valneva, and Bharat Biotech, and organizations, such as UNICEF and WHO, are focusing on preventing the virus by using vaccines. In addition, these organizations are also working on eradicating the virus, and hence, the Japanese encephalitis vaccine has been added to the national immunization plan of various Asian countries, including India and China, which are currently at the highest risk of coming into contact with the Japanese encephalitis virus. Hence, such factors are driving the market growth in Asia during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 8 market companies, including:

Adimmune Corp: The company offers Japanese encephalitis vaccines such as ADImmune that provide comprehensive protection against influenza virus infections.

  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Medigen Inc.
  • Meiji Holdings Co. Ltd.
  • Panacea Biotec Ltd.
  • Sanofi SA
  • Shandong Hengye Biotechnology Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Drivers

Strategic alliances for Japanese encephalitis vaccine development drive the market growth. The global healthcare industry is facing strong downward pressure to minimize costs. Therefore, companies are focusing on forming various strategic alliances across the value chain.  Furthermore, in the global market, such alliances are found primarily on two notes, namely, the alliance between the vendors and industry-academia collaboration.

Moreover, these alliances are usually formed to overcome the challenges associated with the research, manufacturing, and commercialization of vaccines. In addition, these alliances also include the transfer of technology to vendors in specific regions and overcoming the challenges with the approval process at a regional level. Hence, such factors are positively impacting the Japanese encephalitis vaccines market. Therefore, it is expected to drive the market growth during the forecast period.

Significant  Trends

The development of novel Japanese encephalitis vaccine technology is an emerging trend in the market. Japanese encephalitis refers to a mosquito-borne flavivirus disease that is endemic in Asian countries and Western Pacific countries. In addition, as a major share of the global population lives in the Japanese encephalitis endemic region, the indication is currently a major threat to the health of the people in the region.

Moreover, even though different types of vaccines are available for the prevention of the indication, the market still witnesses an unmet need for highly effective vaccines for the prevention of the indication. Therefore, researchers are conducting studies on microribonucleic acid (microRNA) as a potential therapeutic candidate for Japanese encephalitis.  In addition, MicroRNAs are small non-coding ribonucleic acids (RNAs) that contain about 22 nucleotides that are involved in gene expression and regulation across various biological entities.  Hence, such factors are positively impacting the Japanese encephalitis vaccines market.  Therefore, it is expected to drive the market growth during the forecast period.

Major  Challenges

Demand-supply imbalance of Japanese encephalitis vaccines hindering the market growth. As the majority of cases of Japanese encephalitis are seasonal, different manufacturers tend to manufacture the vaccines in large quantities and store them. However, this is often done only by large market players in the market, which can leverage economies of scale, although with increased inventory carrying cost, whereas regional players do not have the scope of doing this.

Moreover, the Japanese encephalitis vaccine, despite being produced in large quantities, faces the risk of low shelf life, as most of these vaccines (on average) have a shelf life of less than two years. In addition, the market faces issues with storage, as these vaccines are required to be stored in cold chain storage. Furthermore, this poses a huge limitation in delivering vaccines to underdeveloped parts of the endemic countries, where the demand is high for these vaccines. Hence, such factors are negatively impacting the Japanese encephalitis vaccines market. Therefore, it is expected to hinder the market growth during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Type Outlook
    • Inactivated vaccines
    • Recombinant vaccines
    • Live attenuated vaccines
  • Distribution Channel Outlook
    • Hospital pharmacy
    • Retail pharmacy
    • Online pharmacy
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Market Analyst Overview

The market addresses the threat of mosquitoborne flavivirus diseases such as yellow fever, dengue, and West Nile viruses, including viral encephalitis. Culex species contribute to the spread, and understanding the symptoms of Japanese encephalitis is crucial. With the rising demand for oral drugs, clinical research and development initiatives play a pivotal role. Ongoing RD (Research and Development) efforts, recent developments, and trade regulations shape the market landscape.

Import/export analysis, production analysis, and value chain optimization contribute to the strategic growth analysis. The market adapts to changes in regulations, emphasizing domestic and localized market players' impact. Identifying emerging revenue pockets and understanding category market growths and application niches are essential aspects of navigating the market.

Japanese Encephalitis Vaccines Market Scope

Report Coverage

Details

Page number

150

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.29%

Market Growth 2024-2028

USD 75.69 million

Market structure

Concentrated

YoY growth 2023-2024(%)

5.55

Regional analysis

Asia, Rest of World (ROW), Europe, and North America

Performing market contribution

Asia at 72%

Key countries

South Korea, Australia, China, India, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., Medigen Inc., Meiji Holdings Co. Ltd., Panacea Biotec Ltd., Sanofi SA, and Shandong Hengye Biotechnology Co. Ltd.

Market dynamics

Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Japanese Encephalitis Vaccines Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the between 2023 and 2028
  • Precise estimation of the size and its contribution to the market in focus on the parent market
  • Detailed market growth analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming market trends and changes in consumer behavior
  • Growth of the market industry across Asia, Rest of World (ROW), Europe, and North America
  • Thorough market growth and forecasting analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market research and growth analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global Japanese encephalitis vaccines market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global japanese encephalitis vaccines market 2018 - 2022 ($ million)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ million)
    • 4.3 Distribution Channel Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Inactivated vaccines - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Inactivated vaccines - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Inactivated vaccines - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Inactivated vaccines - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Inactivated vaccines - Year-over-year growth 2023-2028 (%)
    • 6.4 Recombinant vaccines - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Recombinant vaccines - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Recombinant vaccines - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Recombinant vaccines - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Recombinant vaccines - Year-over-year growth 2023-2028 (%)
    • 6.5 Live attenuated vaccines - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Live attenuated vaccines - Market size and forecast 2023-2028 ($ million)
      • Exhibit 43: Data Table on Live attenuated vaccines - Market size and forecast 2023-2028 ($ million)
      • Exhibit 44: Chart on Live attenuated vaccines - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Live attenuated vaccines - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Type
      • Exhibit 46: Market opportunity by Type ($ million)
      • Exhibit 47: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by Distribution Channel

    • 7.1 Market segments
      • Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
    • 7.2 Comparison by Distribution Channel
      • Exhibit 50: Chart on Comparison by Distribution Channel
      • Exhibit 51: Data Table on Comparison by Distribution Channel
    • 7.3 Hospital pharmacy - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
    • 7.4 Retail pharmacy - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
    • 7.5 Online pharmacy - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
      • Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
      • Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by Distribution Channel
      • Exhibit 64: Market opportunity by Distribution Channel ($ million)
      • Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 Asia - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 North America - Market size and forecast 2023-2028
      • Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 China - Market size and forecast 2023-2028
      • Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.8 India - Market size and forecast 2023-2028
      • Exhibit 91: Chart on India - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on India - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on India - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on India - Year-over-year growth 2023-2028 (%)
    • 9.9 Japan - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.10 South Korea - Market size and forecast 2023-2028
      • Exhibit 99: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on South Korea - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
    • 9.11 Australia - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Australia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 104: Data Table on Australia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 105: Chart on Australia - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Australia - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Adimmune Corp.
              • Exhibit 115: Adimmune Corp. - Overview
              • Exhibit 116: Adimmune Corp. - Product / Service
              • Exhibit 117: Adimmune Corp. - Key offerings
            • 12.4 Bharat Biotech Ltd.
              • Exhibit 118: Bharat Biotech Ltd. - Overview
              • Exhibit 119: Bharat Biotech Ltd. - Product / Service
              • Exhibit 120: Bharat Biotech Ltd. - Key news
              • Exhibit 121: Bharat Biotech Ltd. - Key offerings
            • 12.5 Biological E. Ltd.
              • Exhibit 122: Biological E. Ltd. - Overview
              • Exhibit 123: Biological E. Ltd. - Product / Service
              • Exhibit 124: Biological E. Ltd. - Key offerings
            • 12.6 Medigen Inc.
              • Exhibit 125: Medigen Inc. - Overview
              • Exhibit 126: Medigen Inc. - Product / Service
              • Exhibit 127: Medigen Inc. - Key offerings
            • 12.7 Meiji Holdings Co. Ltd.
              • Exhibit 128: Meiji Holdings Co. Ltd. - Overview
              • Exhibit 129: Meiji Holdings Co. Ltd. - Business segments
              • Exhibit 130: Meiji Holdings Co. Ltd. - Key news
              • Exhibit 131: Meiji Holdings Co. Ltd. - Key offerings
              • Exhibit 132: Meiji Holdings Co. Ltd. - Segment focus
            • 12.8 Panacea Biotec Ltd.
              • Exhibit 133: Panacea Biotec Ltd. - Overview
              • Exhibit 134: Panacea Biotec Ltd. - Product / Service
              • Exhibit 135: Panacea Biotec Ltd. - Key offerings
            • 12.9 Sanofi SA
              • Exhibit 136: Sanofi SA - Overview
              • Exhibit 137: Sanofi SA - Business segments
              • Exhibit 138: Sanofi SA - Key news
              • Exhibit 139: Sanofi SA - Key offerings
              • Exhibit 140: Sanofi SA - Segment focus
            • 12.10 Shandong Hengye Biotechnology Co. Ltd.
              • Exhibit 141: Shandong Hengye Biotechnology Co. Ltd. - Overview
              • Exhibit 142: Shandong Hengye Biotechnology Co. Ltd. - Product / Service
              • Exhibit 143: Shandong Hengye Biotechnology Co. Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 144: Inclusions checklist
                • Exhibit 145: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 146: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 147: Research methodology
                • Exhibit 148: Validation techniques employed for market sizing
                • Exhibit 149: Information sources
              • 13.5 List of abbreviations
                • Exhibit 150: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              japanese encephalitis vaccines market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis